Journal
/
Immunology and Infection
/
Een high-throughput multiplexed screening voor type 1 diabetes, coeliakie en COVID-19
JoVE Journal
Immunology and Infection
This content is Free Access.
JoVE Journal Immunology and Infection
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Please note that all translations are automatically generated. Click here for the English version.

Een high-throughput multiplexed screening voor type 1 diabetes, coeliakie en COVID-19

Nederlands

Automatically Generated

2,388 Views

•

06:46 min

•

July 05, 2022

DOI:

10.3791/63787-v

DOI:
10.3791/63787-v

•

06:46 min
July 05, 2022

•

5 Views
, , , , ,
1Barbara Davis Center for Diabetes,University of Colorado School of Medicine, 2Department of Endocrinology, Guangzhou First People’s Hospital, School of Medicine,South China University of Technology

Summary

Automatically generated

In lijn met de dringende behoefte aan screening op type 1 diabetes, coeliakie en coronavirusziekte 2019, hebben we een high throughput 6-Plex elektrochemiluminescentietest ontwikkeld om tegelijkertijd alle vier de eilandjesautoantilichamen, weefseltransglutaminase autoantilichamen en antilichamen tegen het receptorbindingsdomein van ernstig acuut respiratoir syndroom coronavirus 2 te detecteren.

Explore More Videos

Multiplex AssayAutoantibody ScreeningType 1 DiabetesCeliac DiseaseCOVID-19GAD65SARS-CoV-2 RBDIA-2TTGZnT8ProinsulinBiotinylated AntigenRuthenium-labeled AntigenHigh-throughput ScreeningEarly Disease PredictionPrecise Diagnosis

Read Article

Cite this Article

Jia, X., He, L., Miao, D., Zhang, C., Rewers, M., Yu, L. A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19. J. Vis. Exp. (185), e63787, doi:10.3791/63787 (2022).

Download .ris file

Copy

Share Video

.

Copy